Public-registry site landscape for NCT05639894, a Respiratory Syncytial Virus Immunization study sponsored by Sanofi Pasteur, a Sanofi Company. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05639894 (registry record) |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Condition(s) | Respiratory Syncytial Virus Immunization |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 33 |
| Site countries | United States, Australia, Puerto Rico |
Eichor generates a preliminary site-risk snapshot for NCT05639894 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →